Species variation in the bioactivation of tacrine by hepatic microsomes

References

• Buckpitt A. R., Bahnson L. S., Franklin R. B. Hepatic and pulmonary microsomal metabolism of naphthalene to glutathione adducts: factors affecting the relative rates of conjugate formation. Journal of Pharmacology and Experimental Therapeutics 1984; 231: 291–300
   PubMed Web of Science ®Google Scholar
• Dahlin D. C., Miwa G. T., Lu A. H. Y., Nelson S. D. N-acetyl-p-benzoquinone imine: a cytochrome P450 mediated oxidation of acetaminophen. Proceedings of the National Academy of Sciences, USA 1984; 81: 1327–1331
   PubMed Web of Science ®Google Scholar
• Dahlin D. C., Nelson S. D. Synthesis, decomposition kinetics, and preliminary toxicological studies of N-acetyl-p-benzoquinone imine, a proposed toxic metabolite of acetaminophen. Journal of Medicinal Chemistry 1982; 25: 885–886
   PubMed Web of Science ®Google Scholar
• Davis D. C., Potter W. Z., Jollow D. J., Mitchell J. R. Species differences in hepatic glutathione depletion, covalent binding and hepatic necrosis after acetaminophen. Life Sciences 1974; 14: 2099–2109
   PubMed Web of Science ®Google Scholar
• Farlow M., Gracon S. I., Heshey L. A., Lewis K. W., Sadowsky C. H., Dolan-Ureno J. A controlled trial of tacrine in Alzheimer's patients. Journal of the American Medical Association 1992; 268: 2523–2529
   PubMed Web of Science ®Google Scholar
• Fuhr W., Doehmer J., Buttula N., Wolfel C., Flick I., Klita Y., Staib A. H. Biotransformations of methylxanthines in mammalian cell lines genetically engineered for expression of single cytochromes P450 isoforms. Allocation of metabolic pathways to isotorms and inhibitory effects of quinolones. Toxicology 1993; 82: 169–189
   PubMed Web of Science ®Google Scholar
• Harrison A. C., Kitteringham N. R., Clarke J. B., Park B. K. The mechanism of bioactivation and antigen formation of amodiaquine in the rat. Biochemical Pharmacology 1992; 43: 1421–1430
   PubMed Web of Science ®Google Scholar
• Kadlubar F. F. Biochemical individuality and its implications for drug and carcinogen metabolism: recent insights from acetyltransferase and cytochrome P4501A2 phenotyping and genotyping in humans. Drug Metabolism Reviews 1994; 26: 37–46
   PubMed Web of Science ®Google Scholar
• Lau S. S., Zannoni V. G. Bromobenzene epoxidation leading to binding on macromolecular protein sites. Journal of Pharmacology and Experimental Therapeutics 1981; 219: 563–572
   PubMed Web of Science ®Google Scholar
• Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. J. Protein measurement with folin phenol reagent. Journal of Biological Chemistry 1951; 193: 265–275
   PubMed Web of Science ®Google Scholar
• Madden S., Back D. J., Orme M. L.E. Metabolism of the contraceptive steroid desogestrel by human liver in vitro. Journal of Steroid Biochemistry 1990; 35: 281–288
   Google Scholar
• Madden S., Woolf T. F., Pool W. F., Park B. K. An investigation into the formation of stable, protein-reactive and cytotoxic metabolites from tacrine in vitro: studies with human and rat liver microsomes. Biochemical Pharmacology 1993; 46: 13–20
   PubMed Web of Science ®Google Scholar
• Maggs J. L., Tingle M. D., Kitteringham N. R., Park B. K. Drug-protein conjugates, XIV. Mechanisms of formation of protein-arylating intermediates from amodiaquine, a myelotoxin and hepatotoxin in man. Biochemical Pharmacology 1988; 43: 303–311
   Google Scholar
• Neuberger J., Kenna J. G. Halothane hepatitis. A model of immune mediated drug hepatotoxicity. Clinical Science 1987; 72: 263–270
   PubMed Web of Science ®Google Scholar
• O'Brien J. T., Eagger S., Levy R. Effects of tetrahydroaminoacridine on liver function in patients with Alzheimer's disease. Age and Ageing 1991; 20: 129–131
   PubMedGoogle Scholar
• Omura T., Sato R. The carbon monoxide binding pigment of liver microsomes. Journal of Biological Chemistry 1964; 239: 2370–2378
   PubMed Web of Science ®Google Scholar
• Park B. K., Madden S., Spaldin V., Woolf T. F., Pool W. F. Tacrine transaminitis: potential mechanisms. Alzheimer's Disease and Associated Disorders 1994; 8(Suppl. 2)S39–49
   Google Scholar
• Pool W. F., Bjorge S. M., Change T., Woolf T. F. Metabolic disposition of the cognition activator in man; identification of phenol glucuronides metabolites in urine. ISSX Proceedings of the Fourth North American ISSX Meeting 1992; 2: 164
   Google Scholar
• Spaldin V., Madden S., Woolf T. F., Pool W. F., Park B. K. The effect of enzyme inhibition on the metabolism and activation of tacrine by human liver microsomes. British Journal of Clinical Pharmacology 1994; 38: 15–22
   PubMed Web of Science ®Google Scholar
• Tuma D. J., Klassen L. W. Immune response to acetaldehyde-protein adducts: role in alcoholic liver disease. Gastorenterology 1992; 103: 1969–1973
   PubMed Web of Science ®Google Scholar
• Willson R. A., Hart J., Hall T. The concentration and temporal relationships of acetaminophen-induced changes intracellular and extracellular total glutathione in freshly isolated hepatocytes from untreated and 3-methylcholanthrene pretreated Sprague-Dawley and Fischer rats. Pharmacology and Toxicology 1991; 69: 205–212
   Google Scholar
• Woolf T. F., Pool W. F., Bjorge S. M., Chang T., Goel O. P., Purchase C. F., Schroeder M. C., Kunze K. L., Trager W. F. Bioactivation and irreversible binding of the cognition activator tracrine using human and rat liver microsomal preparations: species differences. Drug Metabolism and Disposition 1993; 21: 874–882
   PubMed Web of Science ®Google Scholar
• Woolf T. F., Pool W. F., Kukan M., Bezek S., Kunze K. L., Trager W. F. (1993) Characterization of tacrine metabolism and bioactivation using heterologous expression systems and inhibition studies: evidence for CYP1A2 involvement. ISSX Fifth North American ISSX Meeting. October, 17–211993
   Google Scholar
• Yokoyama H., Ishii H., Nagata S., Kato S., Kamegaya K., Tsuchiya M. Experimental hepatitis induced by ethanol after immunization with acetaldehyde adducts. Hepatology 1993; 17: 14–19
   PubMed Web of Science ®Google Scholar